DBVTF — DBV Technologies S.A.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1613780 ·
France
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -64,800,000 | -64,500,000 | 215,400,000 | 165,700,000 | 66,800,000 |
| Jun 2026 | 0 | — | -50,600,000 | -50,400,000 | 223,200,000 | 174,900,000 | 62,800,000 |
| Mar 2026 | 0 | — | -47,900,000 | -47,600,000 | 266,400,000 | 229,200,000 | 58,500,000 |
| Dec 2025 | 0 | — | -45,048,000 | -44,829,000 | 233,718,000 | 194,167,000 | 64,948,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-188,476,000
Investing CF
$-6,914,000
Financing CF
$296,060,000
CapEx
$-3,379,000
Dividends Paid
—
Buybacks
$-200,000
EPS Diluted TTM
$-0.68
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$-334,800,000
Inventory
—
Receivables
$17,500,000
ST Investments
—
EBIT TTM
$-208,348,000
Pretax Income TTM
$-206,255,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,762,000
EBITDA
$-205,476,000
Free Cash Flow
$-124,780,752
Enterprise Value
$464,289,824
Total Cash
$165,700,000
Total Debt
$7,500,000
Shares Out
314,203,537
Trailing EPS
$-0.60
Book Value
$0.47
ROE
-205.8%
ROA
-79.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -147,054,000 | -146,947,000 | 233,718,000 | 64,948,000 | 168,770,000 | -121,181,000 |
| Dec 2024 | 0 | -116,590,000 | -113,918,000 | 65,658,000 | 38,271,000 | 27,388,000 | -104,474,000 |
| Dec 2023 | 0 | -76,433,000 | -72,726,000 | 182,986,000 | 42,799,000 | 140,186,000 | -79,653,000 |
| Dec 2022 | 0 | -96,631,000 | -96,274,000 | 246,518,000 | 52,065,000 | 194,454,000 | -55,666,000 |
TTM Snapshot
Revenues TTM
$5,018,000
NetIncome TTM
$-175,993,000
OpCashFlow TTM
—
Assets (Latest)
$223,200,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $247.70B | $457.93 | — |
| GILD | GILEAD SCIENCES, INC. | $211.18B | $170.26 | — |
| MRNA | Moderna, Inc. | $82.56B | $206.80 | — |
| ARGX | ARGENX SE | $58.92B | $947.52 | — |
| BIIB | BIOGEN INC. | $37.07B | $250.79 | — |
News headlines (Yahoo Finance, 1h cache)
DBV Technologies: 3 Key Takeaways for Long-Term Investors
2026-11-18 20:05 · Yahoo
European Equities Traded in the US as American Depositary Receipts Kick Off Week Lower in Monday Trading
2026-11-16 16:21 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise Marginally in Friday Trading
2026-11-13 16:17 · Yahoo
DBV Technologies Highlights New Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years
2026-11-12 15:00 · Yahoo
European Equities Traded in the US as ADRs Tick Higher in Wednesday Trading
2026-11-11 16:12 · Yahoo
DBV Technologies Prepares Peanut Patch Launch as FDA Filing Decision Nears
2026-11-09 15:14 · Yahoo
European Equities Traded in the US as American Depositary Receipts Advance Sharply in Wednesday Trading
2026-11-04 16:13 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline Slightly in Tuesday Trading
2026-11-03 16:23 · Yahoo
DBV Technologies to Participate in Upcoming November Investor Conferences
2026-11-02 21:30 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
2026-11-02 16:16 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.